At a glance
ClinicalIndex Comparison RecordN/ACompleted· 123 enrolled
Drug / intervention
sertraline (Zoloft)drug
Likely dose
sertraline (Zoloft) 25 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted May 30, 2012·Updated Jan 27, 2021
In Brief
An observational study evaluating sertraline (Zoloft) for Posttraumatic Stress Disorder. Completed, enrolled 123 participants across 4 sites.
Detailed Summary
This is a multicenter retrospective study to investigate the dosage regimens of sertraline in the treatment of Posttraumatic Stress Disorder (PTSD) under current medical practice and the efficacy and safety of this drug in patients with PTSD. Data will be collected from the medical records of patients with PTSD.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPosttraumatic Stress Disorder
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 2012
Enrollment StartAug 2012
Primary CompletionOct 2012
TodayJul 2026
First PostedMay 30, 2012
Enrollment StartAug 1, 2012
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.1 years ago
Interventions
sertraline (Zoloft)drug
Dosage form: Tablet, Dosage: over 25 mg/day, duration: Not defined